NU SKIN ASIA PACIFIC INC
NT 10-Q, 1997-08-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: FORSYTH BANCSHARES INC, 10-Q, 1997-08-14
Next: PS FINANCIAL INC, 10QSB, 1997-08-14





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

OMB APPROVAL
OMB Number:  3235-0058
Expires:     May 31, 1997
Estimated  average  burden
hours per response.........2.50

SEC FILE NUMBER
001-12421

CUSIP NUMBER
67018T 10 5 (Class A)
67018T 20 4 (Class B)

(Check One):    |_| Form 10-K       |_| Form 20-F    |_| Form 11-K 

                |X| Form 10-Q    |_| Form 10-N-SAR

                    For Period Ended:    June 30, 1997

        [ ] Transition  Report on Form 10-K
        [ ] Transition Report on Form 20-F 
        [ ] Transition  Report on Form 11-K 
        [ ] Transition Report on Form 10-Q 
        [ ] Transition Report on Form N-SAR
            For the Transition Period Ended: ________________

  Read Instruction (on back page) Before Preparing Form. Please Print or Type.
                Nothing in this form shall be construed to imply
       that the Commission has verified any information contained herein.


If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:


PART I -- REGISTRANT INFORMATION

Nu Skin Asia Pacific, Inc.
Full Name of Registrant

N/A
Former Name if Applicable

75 West Center Street
Address of Principal Executive Office (Street and Number)

Provo, Utah  84601
City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

         (a)    The reasons  described in reasonable  detail in Part III of this
                form  could not be  eliminated  without  unreasonable  effort or
                expense;
|X|      (b)    The subject annual report,  semi-annual  report,  transition
                report on Form 10-K,  Form 20-F,  11-K or Form N-SAR, or portion
                thereof,  will be filed on or before the fifteenth  calendar day
                following  the  prescribed  due date;  or the subject  quarterly
                report of  transition  report on Form 10-Q,  or portion  thereof
                will be filed on or before the fifth  calendar day following the
                prescribed due date; and

         (c)    The  accountant's  statement  or  other  exhibit  required
                by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable  detail the reasons why Forms 10-K,  20-F, 11-K, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period.

See Schedule Part III attached hereto            (Attach Extra Sheets if Needed)

PART IV -- OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification.

     M. Truman Hunt                  801                       345-3005
          Name)                   (Area Code)               (Telephone Number)

(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such report(s) been filed? If answer is no,
     identify report(s).

|X|Yes |_| No

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  or  portion
     thereof? |_| Yes |X| No

(4)  If so, attach an explanation of the anticipated  change,  both  narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

                           Nu Skin Asia Pacific, Inc.
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date:  August 13, 1997                   By: /s/ M. Truman Hunt
                                             M. Truman Hunt,
                                             Vice President of Legal Affairs

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION
                 Intentional misstatements or omissions of fact
          constitute Federal Criminal Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.   This form is  required by Rule  12b-25 (17 CFR  240.12b-25)  of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed  original and four conformed  copies of this form and amendments
     thereto  must be  completed  and filed  with the  Securities  and  Exchange
     Commission,  Washington,  D.C.  20549,  in accordance  with Rule 0-3 of the
     General Rules and Regulations  under the Act. The information  contained in
     or filed  with  the form  will be made a matter  of  public  record  in the
     Commission files.

3.   A manually  signed copy of the form and  amendments  thereto shall be filed
     with each national  securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications  must also be filed on Form 12b-25 but need
     not restate information that has been correctly  furnished.  The form shall
     be clearly identified as an amended notification.

5.   Electronic Filers.  This form shall not be used by electronic filers unable
     to timely  file a report  solely  due to  electronic  difficulties.  Filers
     unable  to  submit  a  report  within  the time  period  prescribed  due to
     difficulties  in  electronic  filing  should comply with either Rule 201 or
     Rule 202 of Regulation  S-T  (ss.232.201  or ss.232.202 of this chapter) or
     apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
     S-T (ss.232.13(b) of this chapter).


                                SCHEDULE PART III
                                 TO FORM 12b-25
                           NOTIFICATION OF LATE FILING
                                    FILED BY
                           NU SKIN ASIA PACIFIC, INC.
                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1997



     Nu Skin Asia Pacific,  Inc., a Delaware  corporation  (the  "Company"),  is
unable to file its Quarterly  Report on Form 10-Q for the quarterly period ended
June 30, 1997 within the prescribed time period without  unreasonable  effort or
expense  because  additional  time is needed to complete the required  financial
reports and related disclosure for the quarter then-ended.  However, the Company
believes  that it will be in a  position  to  complete  the  required  financial
reports and related disclosure within the Rule 12b-25 extension period.

     In addition,  the Company is still gathering additional facts and preparing
disclosure  related to recent  developments  in an audit  initiated by the South
Korean  Customs  Authority of Nu Skin Korea,  Inc.,  the Company's  South Korean
subsidiary.  Because of the fluid nature of this matter, the Company believes it
will  be  better  able  to  gather   additional  facts  regarding  these  recent
developments,  evaluate  the  implications  thereof,  and prepare  any  required
disclosure if it has the additional  time afforded under Rule 12b-25 in which to
file its June 30, 1997 Quarterly Report on Form 10-Q.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission